Fentanyl Withdrawal: Understanding Symptom Severity and Exploring the Role of BMI on Withdrawal Symptoms and Clearance

Original research
par
Luba, Rachel et al

Date de publication

2022

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

Fentanyl is a highly lipophilic mu opioid receptor agonist increasingly found in heroin and other drug supplies that is contributing to marked increases in opioid-related overdose and may be complicating treatment of opioid use disorder (OUD). This study aimed to measure the influence of body mass index (BMI) on fentanyl withdrawal and clearance.

Constatations/points à retenir

High body mass index (BMI) status (overweight or obese) appears to be an important predictor of slower fentanyl clearance and higher SOWS maximum scores across the inpatient period than lower BMI status.

La conception ou méthodologie de recherche

Secondary analysis of an inpatient study (n=150)

Mots clés

About PWUD
Withdrawal
Drug checking
Transitions in care/treatment